In order to confirm that the environment of CSF from PD patients can promote ceruloplasmin modifications, we added purified ceruloplasmin to the CSF of healthy subjects (H) or patients with peripheral neuropathies (PN) or PD, and analysed it before and after incubation for different times. This evidence concerns the gene CP and Parkinson disease.